PHICHEM CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12 CNY | -1.23% |
|
+0.67% | -23.86% |
| Apr. 29 | PhiChem Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 28 | PhiChem Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,739 | 9,063 | 12,373 | 9,004 | 8,262 | 6,291 | - | - |
| Enterprise Value (EV) 1 | 7,739 | 9,063 | 12,373 | 9,404 | 8,979 | 6,434 | 6,295 | 6,291 |
| P/E ratio | 29.9 x | 39.5 x | 32.2 x | 20.4 x | 75 x | 13.8 x | 12.2 x | 13.2 x |
| Yield | - | 0.37% | 0.29% | 0.47% | 0.51% | 1.29% | 2.17% | - |
| Capitalization / Revenue | 5.11 x | 4.86 x | 4.71 x | 3.1 x | 3.03 x | 1.82 x | 1.55 x | 1.46 x |
| EV / Revenue | 5.11 x | 4.86 x | 4.71 x | 3.24 x | 3.29 x | 1.86 x | 1.56 x | 1.46 x |
| EV / EBITDA | 19.8 x | 23.3 x | 20.5 x | 14.6 x | 26.9 x | 8.64 x | 7.39 x | 6.93 x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | 3.21 x | 3.47 x | 3.93 x | 2.56 x | 2.17 x | 1.46 x | 1.34 x | 1.27 x |
| Nbr of stocks (in thousands) | 517,642 | 510,305 | 512,138 | 524,380 | 524,209 | 524,210 | - | - |
| Reference price 2 | 14.95 | 17.76 | 24.16 | 17.17 | 15.76 | 12.00 | 12.00 | 12.00 |
| Announcement Date | 2/27/20 | 3/17/21 | 3/30/22 | 3/30/23 | 4/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,513 | 1,864 | 2,627 | 2,907 | 2,729 | 3,466 | 4,048 | 4,318 |
| EBITDA 1 | 390.3 | 388.2 | 602.9 | 643.9 | 333.6 | 745.1 | 851.6 | 907.9 |
| EBIT 1 | 305.8 | 275.9 | 478.3 | 495 | 151.4 | 549.1 | 660.2 | 654 |
| Operating Margin | 20.21% | 14.8% | 18.21% | 17.03% | 5.55% | 15.85% | 16.31% | 15.15% |
| Earnings before Tax (EBT) 1 | 303.8 | 274.9 | 474.4 | 493.1 | 151.2 | 532.5 | 634.3 | 653 |
| Net income 1 | 255.1 | 229.8 | 385.9 | 434.6 | 112.4 | 442.2 | 519.9 | 481.1 |
| Net margin | 16.86% | 12.33% | 14.69% | 14.95% | 4.12% | 12.76% | 12.84% | 11.14% |
| EPS 2 | 0.5000 | 0.4500 | 0.7500 | 0.8400 | 0.2100 | 0.8700 | 0.9850 | 0.9100 |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | 0.0650 | 0.0700 | 0.0800 | 0.0800 | 0.1550 | 0.2600 | - |
| Announcement Date | 2/27/20 | 3/17/21 | 3/30/22 | 3/30/23 | 4/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 400 | 717 | 144 | 4.52 | - |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 0.6213 x | 2.15 x | 0.1932 x | 0.005311 x | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 11.1% | 9.03% | 10.7% | 12.7% | 2.99% | 11% | 11.8% | 10.9% |
| ROA (Net income/ Total Assets) | 6.21% | 4.48% | 5.62% | - | - | 6.1% | - | - |
| Assets 1 | 4,110 | 5,135 | 6,861 | - | - | 7,248 | - | - |
| Book Value Per Share 2 | 4.660 | 5.120 | 6.150 | 6.720 | 7.250 | 8.200 | 8.990 | 9.420 |
| Cash Flow per Share 2 | 0.3600 | 0.3300 | 0.5000 | 0.7600 | 0.5500 | 0.8100 | 1.020 | 0.7300 |
| Capex 1 | 267 | 261 | 266 | 195 | 271 | 389 | 588 | 586 |
| Capex / Sales | 17.68% | 14% | 10.11% | 6.7% | 9.93% | 11.22% | 14.53% | 13.58% |
| Announcement Date | 2/27/20 | 3/17/21 | 3/30/22 | 3/30/23 | 4/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12
CNY
Average target price
17.65
CNY
Spread / Average Target
+47.11%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.86% | 871M | |
| +1.61% | 49.2B | |
| +16.33% | 41.24B | |
| +18.68% | 25.89B | |
| +12.78% | 19.81B | |
| +0.85% | 17.48B | |
| -21.87% | 15.86B | |
| +2.32% | 15.35B | |
| -10.29% | 15.23B | |
| -22.30% | 13.36B |
- Stock Market
- Equities
- 300398 Stock
- Financials PhiChem Corporation